Turning business intelligence managers into business performance leaders
October 26, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cello, MSI, business leaders, intelligence
Never before have business intelligence people played such a leading role in the marketing planning process. For those who view …
Sharp fall for AstraZeneca
October 26, 2012Sales and Marketing AstraZeneca, Brennan, Q3, Soriot
AstraZeneca saw its third quarter revenue and pre-tax profit both fall 15%, to $6.7 billion and $2 billion, respectively. The …
Astellas announces compliance officer for the Americas
October 26, 2012Manufacturing and Production, Research and Development, Sales and Marketing Astellas, McCauley
Astellas recently named J. Patrick McCauley Jr, a longtime pharmaceutical industry veteran and Astellas employee, to the post of Regional …
Shire poaches new head from Bayer
October 26, 2012Sales and Marketing Angus Russell, Flemming Omskov, Shire
Flemming Ornskov, currently chief marketing officer at Bayer, is to take over at Dublin-based Shire Pharmaceuticals next year. He will …
Contaminated steroids blamed for deadly meningitis outbreak
October 25, 2012Manufacturing and Production FDA, GMP, NECC
As many as 14,000 patients may have been exposed to contaminated steriods that have led to 23 deaths due to …
Lilly censured for rep photo
October 25, 2012Medical Communications, Sales and Marketing ABPI, GP, PMCPA, lilly
Lilly has breached the ABPI’s Code of Practice because one of its representatives insisted on taking pictures of doctors underneath …
AstraZeneca and Ironwood announce $150 million China pact
October 25, 2012Research and Development, Sales and Marketing AstraZeneca, China, IBS, Ironwood
AstraZeneca has signed a deal with Ironwood to co-develop and co-market Ironwood’s irritable bowel syndrome treatment in China. In August …
Perception of pharma online ‘negative’
October 25, 2012Medical Communications, Sales and Marketing Digital Health Coalition, Endo, WEGO Health
Pharma manufacturers must take to social media in a bid to correct misinformation about the industry and their products, according …
Management Forum NSF-DBA Medical Devices Certification Programme
October 24, 2012Research and Development
Management Forum has teamed up with NSF-DBA, experts in medical device professional training, to bring certification programmes aimed at demonstrating …
European green light for Novo’s Tresiba
October 24, 2012Sales and Marketing EMA, Novo Nordisk, Tresiba
The European Medicines Agency has given the go-ahead for Novo Nordisk’s Tresiba, a new basal analogue insulin to treat diabetes …
Streamlining Key Services your Drug Delivery Device Partner Provides
October 24, 2012Manufacturing and Production auto injector, autoinjector, final assembly, pen injector, shl group, shl pharma
Extensive project management expertise and logistical control know-how are obviously required when working on a combination product from the concept …
Merck Serono’s Christoph Schnorr joins Quintiles
October 24, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Christoph Schnorr, Quintiles
Dr Christoph Schnorr has joined Quintiles as head of its European Research and Development consulting practice. Schnorr joins quintiles from Merck …
UK medicine costs ‘under control’
October 24, 2012Sales and Marketing ABPI, PCT, R&D, UK medicine
The ABPI has seized on two reports – one its own and one independent – published this week to assert …
Turkey ‘can be pharma R&D, production hub by 2023’, says PwC
October 23, 2012Manufacturing and Production, Research and Development, Sales and Marketing R&D, Turkey, pwC
Despite lagging behind its peers among ‘pharmerging’ economies, Turkey has the potential to become a major R&D and production hub …
FDA committee recommends Kynamro
October 23, 2012Research and Development, Sales and Marketing FDA, Genzyme, Kynamro, Sanofi
Sanofi’s anti-cholestrol drug Kynamro has been recommended by an FDA committee, paving the way for US approval early next year. …
Dr Reddy’s offers €27m for Dutch formulation firm OctoPlus
October 23, 2012Manufacturing and Production Dr Reddy's, OctoPlus, outsourcing
India’s Dr Reddy’s Laboratories has signed an agreement to buy Netherlands-based formulation and drug delivery specialist OctoPlus in a €27m …
WuXi cuts ribbon on biologics plant
October 23, 2012Manufacturing and Production CGMP, WuXi AppTec
China’s WuXi AppTec has officially opened a new biologics manufacturing facility that forms the centrepiece of the company’s recently-signed alliance …
Pfizer buys NextWave Pharmaceuticals
October 23, 2012Sales and Marketing ADHD, Pfizer, Qullivant, nextwave
Pfizer is to acquire NextWave Pharmaceuticals by the end of the year in a deal that could be worth $680 …
Amgen’s Roger Perlmutter joins Heptares
October 23, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Amgen, Heptares, Roger Perlmutter
GPCR drug discovery firm Heptares Therapeutics has elected Dr Roger Perlmutter, the former executive VP, Research and Development, at Amgen …
Coping with transformational change – the key to winning
October 22, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Moorhouse
Imagine you are investing £3.4 billion in changing your business, half of it in business-critical projects such as drug supply …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
